All Stories

  1. Bacterial communities co-develop with respiratory immunity early in life, linking dysbiosis to systemic monocyte signature and wheezing
  2. Age-dependent expression and antiviral activity of interferon epsilon in respiratory epithelium
  3. Deep multiomic profiling reveals molecular signatures that underpin preschool wheeze and asthma
  4. Service development project to pilot a digital technology innovation for video direct observation of therapy in adult patients with asthma
  5. Time to re-set our thinking about airways disease: lessons from history, the resurgence of chronic bronchitis / PBB and modern concepts in microbiology
  6. Role of oral corticosteroids in the treatment of acute preschool wheeze
  7. Medication Adherence in Children with Asthma
  8. Review of the Safety, Efficacy and Tolerability of Palivizumab in the Prevention of Severe Respiratory Syncytial Virus (RSV) Disease
  9. Reducing oral steroid intolerability and drug costs for acute wheezers: A retrospective evaluation of a clinical management algorithm in a Pediatric Emergency Department
  10. The use of remote video directly observed therapy to improve both inhaler technique and adherence to asthma medications
  11. History Taking as a Diagnostic Tool in Children With Chronic Cough
  12. Diagnostic value of mid-regional pro-Adrenomedullin as a biomarker of invasive bacterial infection in children: a systematic review
  13. How we teach children with asthma to use their inhaler: a scoping review
  14. Implementation of a Children's Safe Asthma Discharge Care Pathway Reduces the Risk of Future Asthma Attacks in Children–A Retrospective Quality Improvement Report
  15. Early life inter-kingdom interactions shape the immunological environment of the airways
  16. Inhibition of the TLR4 signalling pathway with TAK-242 reduces RSV infection and cytokine release in primary airway epithelial cells
  17. Mobile video directly observed therapy can be used to improve at-home inhaler technique in children with asthma
  18. Can omalizumab be used effectively to treat severe conjunctivitis in children with asthma? A case example and review of the literature
  19. Paediatric pneumonia: a guide to diagnosis, investigation and treatment
  20. Validating clinical practice guidelines for the management of children with non-blanching rashes in the UK (PiC): a prospective, multicentre cohort study
  21. Respiratory syncytial virus prophylaxis for prevention of recurrent childhood wheeze and asthma: a systematic review
  22. Seroprevalence of SARS-CoV-2 antibodies in children of United Kingdom healthcare workers: a prospective multicentre cohort study protocol
  23. Diagnostic test accuracy of point-of-care procalcitonin to diagnose serious bacterial infections in children
  24. VP10.21: Evolving management of congenital pulmonary airway malformations in a single centre
  25. How we teach children with asthma to use their inhaler: a scoping review protocol
  26. Use of oximetry to screen for paediatric obstructive sleep apnoea: is one night enough and is 6 hours too much?
  27. Characteristics of Reported Pediatric Medication Errors in Northern Ireland and Use in Quality Improvement
  28. Loop-mediated isothermal amplification for the early diagnosis of invasive meningococcal disease in children
  29. Aerosol Therapy in Asthma–Why We Are Failing Our Patients and How We Can Do Better
  30. The ERS approach to e-cigarettes is entirely rational
  31. A protocol for a systematic review and meta-analysis of the diagnostic accuracy of mid-regional pro-adrenomedullin in predicting invasive bacterial infection in children
  32. Comparative primary paediatric nasal epithelial cell culture differentiation and RSV-induced cytopathogenesis following culture in two commercial media
  33. Exposure and attitudes to adolescent health amongst Paediatric trainees in Northern Ireland: a mixed-methods study
  34. Respiratory syncytial virus prophylaxis for prevention of recurrent childhood wheeze and asthma: a protocol for a systematic review
  35. Wet Cough and Nasal Symptoms in Children: Can We Do Better?
  36. Comparative Therapeutic Potential of ALX-0171 and Palivizumab against Respiratory Syncytial Virus Clinical Isolate Infection of Well-Differentiated Primary Pediatric Bronchial Epithelial Cell Cultures
  37. A Structured Multidisciplinary Approach to Managing Difficult-to-Treat Asthma in Children
  38. Fifteen-minute consultation: Symptoms and signs of meningococcal disease
  39. Investigating the clinical use of structured light plethysmography to assess lung function in children with neuromuscular disorders
  40. What causes prescribing errors in children? Review of existing evidence
  41. Airway Epithelial Derived Cytokines and Chemokines and Their Role in the Immune Response to Respiratory Syncytial Virus Infection
  42. Parents’ and clinicians’ views on conducting paediatric diagnostic test accuracy studies without prior informed consent: qualitative insight from the Petechiae in Children study (PiC)
  43. P542 RSV prophylaxis for prevention of recurrent childhood wheeze: a systematic review
  44. The child with an incessant dry cough
  45. Early life innate immune responses to RSV in cystic fibrosis airway epithelium
  46. Identification of novel factors associated with severe respiratory syncytial virus disease in infants
  47. Influence of gestational and developmental age on human airway epithelial innate immune responses to Respiratory Syncytial Virus (RSV) in early life
  48. A systematic review of the diagnostic accuracy of Loop-mediated-isothermal AMPlification (LAMP) in the diagnosis of invasive meningococcal disease in children
  49. Correction: Characterisation of morphological differences in well-differentiated nasal epithelial cell cultures from preterm and term infants at birth and one-year
  50. Characterisation of morphological differences in well-differentiated nasal epithelial cell cultures from preterm and term infants at birth and one-year
  51. Respiratory Syncytial Virus and Asthma Inception: Cause and Effect, or Shared Susceptibility?
  52. Causes of variability in latent phenotypes of childhood wheeze
  53. Point-of-care testing for procalcitonin in identifying bacterial infections in young infants: a diagnostic accuracy study
  54. The “Petechiae in children” (PiC) study: evaluating potential clinical decision rules for the management of feverish children with non-blanching rashes, including the role of point of care testing for Procalcitonin & Neisseria meningitidis DNA – a stud...
  55. The impact of fetal umbilical artery Doppler pulsatility index on childhood respiratory function and atopy – A prospective case-control study
  56. A protocol for a systematic review of the diagnostic accuracy of Loop-mediated-isothermal AMPlification (LAMP) in diagnosis of invasive meningococcal disease in children
  57. At-risk children with asthma (ARC): a systematic review
  58. Pulmonary epithelial barrier and immunological functions at birth and in early life - key determinants of the development of asthma?  A description of the protocol for the Breathing Together study
  59. Habit-tic cough: Presentation and outcome with simple reassurance
  60. Mobile direct observation of therapy (MDOT) - A rapid systematic review and pilot study in children with asthma
  61. S62 Identifying the child (5–12 years) with asthma at increased risk of attacks: the at-risk child with asthma (arc) systematic review
  62. Pro-inflammatory mediator responses from neonatal airway epithelial cells and early childhood wheeze
  63. The impact of financial incentives on the implementation of asthma or diabetes self-management: A systematic review
  64. Is follow up chest X-ray required in children with round pneumonia?
  65. ERS statement on protracted bacterial bronchitis in children
  66. Azithromycin for episodes with asthma-like symptoms in young children aged 1–3 years
  67. Management of bronchiolitis in infants: key clinical questions
  68. How evidenced based and up to date are our cough guidelines?
  69. Loop-mediated isothermal amplification assay for rapid detection of Streptococcus agalactiae (group B streptococcus) in vaginal swabs – a proof of concept study
  70. Interventions to prevent and treat corticosteroid-induced osteoporosis and prevent osteoporotic fractures in Duchenne muscular dystrophy
  71. Protocol for a systematic review to identify and weight the indicators of risk of asthma exacerbations in children aged 5–12 years
  72. A comparison of different pre-lysis methods and extraction kits for recovery of Streptococcus agalacticae (Lancefield group B Streptococcus ) DNA from whole blood
  73. Blood Pressure in Young Adults Born at Very Low Birth Weight
  74. Building bridges for innovation in ageing: Synergies between Action Groups of the EIP on AHA
  75. The impact of incentives on the implementation of asthma or diabetes self-management: A systematic review
  76. The epidemiology, healthcare and societal burden and costs of asthma in the UK and its member nations: analyses of standalone and linked national databases
  77. Structural and Functional Lung Impairment in Adult Survivors of Bronchopulmonary Dysplasia
  78. Scaling up strategies of the chronic respiratory disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3: Area 5)
  79. Fetal umbilical artery Doppler pulsatility index and childhood neurocognitive outcome at 12 years
  80. EGFR Interacts with the Fusion Protein of Respiratory Syncytial Virus Strain 2-20 and Mediates Infection and Mucin Expression
  81. Genomic Meningococcal Load in the Nasopharynx of Children with Meningococcal Disease
  82. Night-to-night variation of pulse oximetry in children with sleep-disordered breathing
  83. The common vaginal commensal bacterium Ureaplasma parvum is associated with chorioamnionitis in extreme preterm labor
  84. Efficacy and long‐term outcomes of palivizumab prophylaxis to prevent respiratory syncytial virus infection in infants with cystic fibrosis in Northern Ireland
  85. In Vitro Modeling of RSV Infection and Cytopathogenesis in Well-Differentiated Human Primary Airway Epithelial Cells (WD-PAECs)
  86. Response to letter by Popov, Todor regarding our paper: Exhaled breath temperature measurement and asthma control in children prescribed inhaled corticosteroids: A cross sectional study
  87. Clinical Evaluation of Streptococcus pneumoniae Polymerase Chain Reaction in Children with Suspected Septicemia
  88. Challenges of harmonising data from UK national health surveys: a case study of attempts to estimate the UK prevalence of asthma
  89. Respiratory syncytial virus and type III interferon responses
  90. Performance of a Novel Molecular Method in the Diagnosis of Late-Onset Sepsis in Very Low Birth Weight Infants
  91. Blood eosinophils as a marker of likely corticosteroid response in children with preschool wheeze: time for an eosinophil guided clinical trial?
  92. Primary airway epithelial cell culture and asthma in children-lessons learnt and yet to come
  93. Respiratory syncytial virus, an ongoing medical dilemma: an expert commentary on respiratory syncytial virus prophylactic and therapeutic pharmaceuticals currently in clinical trials
  94. Epidermal Growth Factor Removal or Tyrphostin AG1478 Treatment Reduces Goblet Cells & Mucus Secretion of Epithelial Cells from Asthmatic Children Using the Air-Liquid Interface Model
  95. Clinical and Cost-Effectiveness of Procalcitonin Test for Prodromal Meningococcal Disease–A Meta-Analysis
  96. Diagnostic accuracy of loop-mediated isothermal amplification as a near-patient test for meningococcal disease in children: an observational cohort study
  97. Exhaled breath temperature measurement and asthma control in children prescribed inhaled corticosteroids: A cross sectional study
  98. Adherence to treatment in children and adolescents with cystic fibrosis: a cross-sectional, multi-method study investigating the influence of beliefs about treatment and parental depressive symptoms
  99. Susceptibility to Invasive Meningococcal Disease: Polymorphism of Complement System Genes and Neisseria meningitidis Factor H Binding Protein
  100. Human Parechovirus Infection in Neonatal Intensive Care
  101. Estimating the incidence, prevalence and true cost of asthma in the UK: secondary analysis of national stand-alone and linked databases in England, Northern Ireland, Scotland and Wales—a study protocol
  102. Erratum: A 3-D well-differentiated model of pediatric bronchial epithelium demonstrates-unstimulated morphological differences between asthmatic and nonasthmatic cells
  103. Pertussis: a significant cause of prolonged acute cough in previously vaccinated school-aged children
  104. Integrated care pathways for airway diseases (AIRWAYS-ICPs)
  105. Interventions to prevent steroid-induced osteoporosis and osteoporotic fractures in Duchenne muscular dystrophy
  106. Nasal Epithelial Cells Can Act as a Physiological Surrogate for Paediatric Asthma Studies
  107. Fetal umbilical artery Doppler pulsatility index as a predictor of cardiovascular risk factors in children – a long-term follow up study
  108. Population pharmacokinetic and pharmacogenetic analysis of tacrolimus in paediatric liver transplant patients
  109. Children must be protected from the tobacco industry's marketing tactics
  110. Relative Respiratory Syncytial Virus Cytopathogenesis in Upper and Lower Respiratory Tract Epithelium
  111. Parents' experiences of caring for their infant following surgery in the neonatal period: A literature review
  112. Potassium canrenoate treatment in paediatric patients
  113. The management of acute bronchiolitis in infants
  114. Chronic cough in children
  115. Chronic IL9 and IL-13 Exposure Leads to an Altered Differentiation of Ciliated Cells in a Well-Differentiated Paediatric Bronchial Epithelial Cell Model
  116. Postoperative pulmonary calcification in a child with truncus arteriosus
  117. Respiratory syncytial virus interaction with human airway epithelium
  118. Prophylactic ranitidine treatment in critically ill children - a population pharmacokinetic study
  119. Can Certain Genotypes Predispose to Poor Asthma Control in Children? A Pharmacogenetic Study of 9 Candidate Genes in Children with Difficult Asthma
  120. Cough
  121. The difficult coughing child: prolonged acute cough in children
  122. Population pharmacokinetic model of canrenone after intravenous administration of potassium canrenoate to paediatric patients
  123. In vitro modeling of respiratory syncytial virus infection of pediatric bronchial epithelium, the primary target of infection in vivo
  124. Genetic susceptibility to invasive meningococcal disease: MBL2 structural polymorphisms revisited in a large case-control study and a systematic review
  125. Asthma deaths: we need to identify risk factors early and construct at-risk asthma registers
  126. IL-31 does not induce normal human ciliated epithelial cells to differentiate into a phenotype consistent with the pathophysiology of asthma
  127. Development and validation of a dried blood spot LC–MS/MS assay to quantify ranitidine in paediatric samples
  128. Is dieting behaviour decreasing in young adolescents?
  129. The 'unified airway': the RCPCH care pathway for children with asthma and/or rhinitis
  130. Comparative repeatability of two handheld fractional exhaled nitric oxide monitors
  131. Molecular testing of respiratory swabs aids early recognition of meningococcal disease in children
  132. A20 Regulation of Nuclear Factor–κB
  133. Vapor rub appears to decrease nighttime cough in children with upper respiratory infections
  134. Development and clinical validation of a loop-mediated isothermal amplification method for the rapid detection of Neisseria meningitidis
  135. Effects of IL-13 on Mucociliary Differentiation of Pediatric Asthmatic Bronchial Epithelial Cells
  136. Differential cytopathogenesis of respiratory syncytial virus prototypic and clinical isolates in primary pediatric bronchial epithelial cells
  137. High concentrations of pepsin in bronchoalveolar lavage fluid from children with cystic fibrosis are associated with high interleukin-8 concentrations
  138. Peanut allergy and allergic airways inflammation
  139. Does airway allergic inflammation pre-exist before late onset wheeze in children?
  140. Cytopathogenesis of Sendai Virus in Well-Differentiated Primary Pediatric Bronchial Epithelial Cells
  141. Respiratory viral infection in lower airways of asymptomatic children
  142. A 3-D Well-Differentiated Model of Pediatric Bronchial Epithelium Demonstrates Unstimulated Morphological Differences Between Asthmatic and Nonasthmatic Cells
  143. Pepsin measured in induced sputum—a test for pulmonary aspiration in children?
  144. Influence of ABCB1 polymorphisms and haplotypes on tacrolimus nephrotoxicity and dosage requirements in children with liver transplant
  145. Misdiagnosis in the time of meningitis
  146. Non-specific isolated persistent cough
  147. Should long-haul flights carry antibiotics on board to treat acute bacterial meningitis and meningococcal septicaemia?
  148. Recommendations for the assessment and management of cough in children
  149. A meta‐analysis of the association between Caesarean section and childhood asthma
  150. Diagnosing chronic cough in children
  151. Pepsin in bronchoalveolar lavage fluid: a specific and sensitive method of diagnosing gastro-oesophageal reflux–related pulmonary aspiration
  152. Children with stable asthma have reduced airway matrix metalloproteinase‐9 and matrix metalloproteinase‐9/tissue inhibitor of metalloproteinase‐1 ratio
  153. The endoscopic appearance of the oesophago-gastric junction during 'J Manoeuvre' is associated with gastro-oesophageal reflux
  154. Assessment of gastro-oesophageal reflux symptoms in children
  155. Monitoring growth in asthmatic children treated with high dose inhaled glucocorticoids does not predict adrenal suppression
  156. Two in a Bed, does Helicobacter Pylori Spread?
  157. The effect of nicotine on basophil histamine release
  158. Exhaled Nitric Oxide in Relation to the Clinical Features of Childhood Asthma
  159. Home Heating and Respiratory Symptoms among Children in Belfast, Northern Ireland
  160. A Meta-Analysis of the Association Between Childhood Type 1 Diabetes and Atopic Disease
  161. Non‐bronchoscopic sampling and culture of bronchial epithelial cells in children
  162. Fast and Frugal Models of Clinical Judgment in Novice and Expert Physicians
  163. Interleukin-4 and interleukin-4 soluble receptor α levels in bronchoalveolar lavage from children with asthma
  164. T cell cytokine profiles in childhood asthma
  165. Exhaled nitric oxide correlates with airway eosinophils in childhood asthma
  166. Outgrown asthma does not mean no airways inflammation
  167. The repeatability of nonbronchoscopic bronchoalveolar lavage differential cell counts
  168. The use of polymeric solid phase extraction and HPLC analysis for the determination of ranitidine in routine plasma samples obtained from paediatric patients
  169. Acute Asthma Exacerbations and Air Pollutants in Children Living in Belfast, Northern Ireland
  170. Antioxidants and Protein Carbonyls in Bronchoalveolar Lavage Fluid of Children: Normal Data
  171. Chronic cough in children: bronchoalveolar lavage findings
  172. Inflammatory mediators in bronchoalveolar lavage samples from children with and without asthma
  173. 16th All Ireland social medicine meeting
  174. Bronchoalveolar lavage findings suggest two different forms of childhood asthma
  175. High-dose inhaled steroids in asthmatic children
  176. Growth and adrenal suppression in asthmatic children treated with high-dose fluticasone propionate
  177. Investigating paediatric airways by non‐bronchoscopic lavage: normal cellular data
  178. Infantile spasms associated with theophylline toxicity